I’m no CAE analyst - although I could play one on TV - but with a father in refrigeration, I’ve always been interested in the intricacies of heat flow and transfer.
Many of today's important discoveries - life-saving drugs, vaccines, biotechnology-derived therapies - can be destroyed in transit by exposure to temperatures that are too hot or too cold. After investing heavily on R&D and production, pharmaceutical, biotech and healthcare companies all face the same dilemma:
How can we protect our temperature-sensitive products and meet government regulations?
Maya used NX Advanced Simulation – namely NX Flow and NX Thermal (PDFs) – for the simulation of CCT’s boxes. Their simulation results and digital validation provided a technological edge for this cold chain company.
From the article: “A computer program used during the modeling process lets the user pass through a number of required steps, including analysis selection, geometry creation, element selection, boundary condition application, and program execution….Comparison of simulation results and actual chamber test data has shown that CCT now has the capability to reliably model phase change of its refrigerants in a stagnant air (free convection) environment.”